Cargando…

Serum and cerebrospinal fluid tau protein level as biomarkers for evaluating acute spinal cord injury severity and motor function outcome

Tau protein, a microtubule-associated protein, has a high specific expression in neurons and axons. Because traumatic spinal cord injury mainly affects neurons and axons, we speculated that tau protein may be a promising biomarker to reflect the degree of spinal cord injury and prognosis of motor fu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tang, Ying, Liu, Hong-Liang, Min, Ling-Xia, Yuan, Hao-Shi, Guo, Lei, Han, Peng-Bo, Lu, Yu-Xin, Zhong, Jian-Feng, Wang, Dong-Lin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6375043/ https://www.ncbi.nlm.nih.gov/pubmed/30688276 http://dx.doi.org/10.4103/1673-5374.249238

Ejemplares similares

Biomarkers for Severity of Spinal Cord Injury in the Cerebrospinal Fluid of Rats
por: Lubieniecka, Joanna M., et al.
Publicado: (2011)

Parallel Metabolomic Profiling of Cerebrospinal Fluid and Serum for Identifying Biomarkers of Injury Severity after Acute Human Spinal Cord Injury
por: Wu, Yiman, et al.
Publicado: (2016)

Parallel Metabolomic Profiling of Cerebrospinal Fluid, Plasma, and Spinal Cord to Identify Biomarkers for Spinal Cord Injury
por: Yang, Hua, et al.
Publicado: (2021)

Association between Cerebrospinal Fluid and Serum Biomarker Levels and Diagnosis, Injury Severity, and Short-Term Outcomes in Patients with Acute Traumatic Spinal Cord Injury
por: Yang, Zhihui, et al.
Publicado: (2023)

Serum and Cerebrospinal Fluid Levels of S-100β Is A Biomarker for Spinal Cord Injury; a Systematic Review and Meta-Analysis
por: Faridaalee, Gholamreza, et al.
Publicado: (2019)

Amyloid and tau cerebrospinal fluid biomarkers in HIV infection
por: Gisslén, Magnus, et al.
Publicado: (2009)

Comparative Analysis of Cytokine Profiles in Cerebrospinal Fluid and Blood Serum in Patients with Acute and Subacute Spinal Cord Injury
por: Sabirov, Davran, et al.
Publicado: (2023)

Blood amyloid and tau biomarkers as predictors of cerebrospinal fluid profiles
por: Delaby, Constance, et al.
Publicado: (2022)

Arachidonic acid pathway alterations in cerebrospinal fluid of dogs with naturally occurring spinal cord injury
por: Russell, Rae L., et al.
Publicado: (2016)

The ultrastructure of spinal cord perivascular spaces: Implications for the circulation of cerebrospinal fluid
por: Lam, Magdalena A., et al.
Publicado: (2017)

STUDIES ON THE TRANSFERRINS OF ADULT SERUM, CORD SERUM, AND CEREBROSPINAL FLUID : THE EFFECT OF NEURAMINIDASE
por: Parker, W. Carey, et al.
Publicado: (1962)

Glycan biomarkers for Alzheimer disease correlate with T‐tau and P‐tau in cerebrospinal fluid in subjective cognitive impairment
por: Schedin‐Weiss, Sophia, et al.
Publicado: (2020)

Cerebrospinal fluid and peripheral blood proteomics in Traumatic Spinal Cord Injury: A prospective pilot study
por: Wichmann, Thea Overgaard, et al.
Publicado: (2022)

Tau oligomers in cerebrospinal fluid in Alzheimer's disease
por: Sengupta, Urmi, et al.
Publicado: (2017)

Comparing Tau PET Visual Interpretation with Tau PET Quantification, Cerebrospinal Fluid Biomarkers, and Longitudinal Clinical Assessment
por: Chen, Charles D., et al.
Publicado: (2023)

Cerebrospinal fluid drains reduce risk of spinal cord injury for thoracic/thoracoabdominal aneurysm surgery: A review
por: Epstein, Nancy E.
Publicado: (2018)

The Study of Cerebrospinal Fluid microRNAs in Spinal Cord Injury and Neurodegenerative Diseases: Methodological Problems and Possible Solutions
por: Baichurina, Irina, et al.
Publicado: (2021)

Cerebrospinal Fluid P-Tau(181P): Biomarker for Improved Differential Dementia Diagnosis
por: Struyfs, Hanne, et al.
Publicado: (2015)

Searching for novel cerebrospinal fluid biomarkers of tau pathology in frontotemporal dementia: an elusive quest
por: Foiani, Martha S, et al.
Publicado: (2019)

Association of serum Apolipoprotein B with cerebrospinal fluid biomarkers of Alzheimer’s pathology
por: Hu, Hao, et al.
Publicado: (2020)

Changes in cerebrospinal fluid and serum cytokine levels in severe traumatic brain injury patients
por: Saito, T, et al.
Publicado: (2012)

Cerebrospinal Fluid Pressure Dynamics as a Bedside Test in Traumatic Spinal Cord Injury to Assess Surgical Spinal Cord Decompression: Safety, Feasibility, and Proof-of-Concept
por: Kheram, Najmeh, et al.
Publicado: (2023)

Serum and Cerebrospinal Fluid Cytokine Biomarkers for Diagnosis of Multiple Sclerosis
por: Martynova, Ekaterina, et al.
Publicado: (2020)

Motor Progression in Early-Stage Parkinson's Disease: A Clinical Prediction Model and the Role of Cerebrospinal Fluid Biomarkers
por: Ma, Ling-Yan, et al.
Publicado: (2021)

Cerebrospinal fluid p-tau217 performs better than p-tau181 as a biomarker of Alzheimer’s disease
por: Janelidze, Shorena, et al.
Publicado: (2020)

Lysophosphatidic acids and their substrate lysophospholipids in cerebrospinal fluid as objective biomarkers for evaluating the severity of lumbar spinal stenosis
por: Hayakawa, Kentaro, et al.
Publicado: (2019)

Cerebrospinal fluid drainage and blood pressure elevation to treat acute spinal cord infarct
por: Strohm, Tamara A., et al.
Publicado: (2018)

Cerebrospinal Fluid Analysis in Recumbent Adult Dairy Cows With or Without Spinal Cord Lesions
por: Achard, D., et al.
Publicado: (2017)

Editorial: Advances in Spinal Cord Epidural Stimulation for Motor and Autonomic Functions Recovery After Severe Spinal Cord Injury
por: Rejc, Enrico, et al.
Publicado: (2022)

Influence of spinal cord injury on core regions of motor function
por: Shen, Xiao-Yan, et al.
Publicado: (2020)

Cerebrospinal fluid levels of GFAP and pNF-H are elevated in patients with chronic spinal cord injury and neurological deterioration
por: Holmström, Ulrika, et al.
Publicado: (2020)

Transplantation of autologous bone marrow–derived mononuclear cells into cerebrospinal fluid in a canine model of spinal cord injury
por: Nakamoto, Yuya, et al.
Publicado: (2023)

Racial Disparity in Cerebrospinal Fluid Amyloid and Tau Biomarkers and Associated Cutoffs for Mild Cognitive Impairment
por: Garrett, Stephanie L., et al.
Publicado: (2019)

Blood Serum Cytokines in Patients with Subacute Spinal Cord Injury: A Pilot Study to Search for Biomarkers of Injury Severity
por: Ogurcov, Sergei, et al.
Publicado: (2021)

Tau protein as a possible marker of cerebrospinal fluid leakage in cerebrospinal fluid rhinorrhoea: A pilot study
por: Oudart, Jean-Baptiste, et al.
Publicado: (2017)

Delayed Imatinib Treatment for Acute Spinal Cord Injury: Functional Recovery and Serum Biomarkers
por: Kjell, Jacob, et al.
Publicado: (2015)

Cerebrospinal fluid biomarkers for assessing Huntington disease onset and severity
por: Caron, Nicholas S, et al.
Publicado: (2022)

Effect of long-term storage in biobanks on cerebrospinal fluid biomarker Aβ(1-42), T-tau, and P-tau values
por: Willemse, Eline A.J., et al.
Publicado: (2017)

Cerebrospinal fluid and serum biomarkers of cerebral malaria mortality in Ghanaian children
por: Armah, Henry B, et al.
Publicado: (2007)

ADDITIONAL STUDIES ON THE TRANSFERRINS OF CORD SERUM AND CEREBROSPINAL FLUID : VARIATION IN CARBOHYDRATE PROSTHETIC GROUPS
por: Parker, W. Carey, et al.
Publicado: (1963)

Cannot write session to /tmp/vufind_sessions/sess_q48chufe9thfmj1thdnroqe2ih